We are live on ! Find out more
ELV icon

Elevance Health
ELV

1,596 hedge funds and large institutions have $76.6B invested in Elevance Health in 2026 Q2 according to their latest regulatory filings, with 262 funds opening new positions, 589 increasing their positions, 540 reducing their positions, and 104 closing their positions.

New
Increased
Maintained
Reduced
Closed

152% more first-time investments, than exits

New positions opened: 262 | Existing positions closed: 104

34% more capital invested

Capital invested by funds: $57B → $76.6B (+$19.6B)

30% more funds holding in top 10

Funds holding in top 10: 20 → 26 (+6)

14% more call options, than puts

Call options by funds: $543M | Put options by funds: $475M

9% more funds holding

Funds holding: 1,468 → 1,596 (+128)

3.27% more ownership

Funds ownership: 88.27% → 91.54% (+3.3%)

9% more repeat investments, than reductions

Existing positions increased: 589 | Existing positions reduced: 540

Holders
1,596
Holders Change
+128
Holders Change %
+8.72%
% of All Funds
19.28%
Holding in Top 10
26
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+30%
% of All Funds
0.31%
New
262
Increased
589
Reduced
540
Closed
104
Calls
$543M
Puts
$475M
Net Calls
+$67.6M
Net Calls Change
-$192M

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$689M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$429M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$365M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$349M
5
AACR
ACR Alpine Capital Research
Missouri
+$274M

Top Sellers

Rank Fund Capital Flow
1
Amundi
Amundi
France
-$389M
2
Bank of America
Bank of America
North Carolina
-$338M
3
BlackRock
BlackRock
New York
-$332M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$271M
5
Citadel Advisors
Citadel Advisors
Florida
-$243M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$7.34B -$332M -896,021 -5%
Vanguard Capital Management
2
Vanguard Capital Management
Pennsylvania
$5.44B -$107M -287,255 -2%
State Street
3
State Street
Massachusetts
$4.03B +$51.1M +137,914 +1%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$3.56B +$365M +984,976 +12%
Vanguard Portfolio Management
5
Vanguard Portfolio Management
Pennsylvania
$2.4B -$52.6M -141,721 -2%
Sanders Capital
6
Sanders Capital
Florida
$2.25B -$25.7M -69,279 -1%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$1.99B -$9.86M -26,583 -0.5%
Harris Associates
8
Harris Associates
Illinois
$1.9B +$47.5M +127,985 +3%
Artisan Partners
9
Artisan Partners
Wisconsin
$1.77B -$202M -545,953 -11%
Invesco
10
Invesco
Georgia
$1.64B -$216M -583,179 -12%
First Eagle Investment Management
11
First Eagle Investment Management
New York
$1.62B +$20.7M +55,905 +1%
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$1.55B -$271M -731,594 -15%
Norges Bank
13
Norges Bank
Norway
$1.53B +$1.47B +3,958,856 New
Bank of New York Mellon
14
Bank of New York Mellon
New York
$1.25B +$140M +377,507 +13%
Fidelity Investments
15
Fidelity Investments
Massachusetts
$1.21B +$429M +1,155,933 +59%
Morgan Stanley
16
Morgan Stanley
New York
$1.01B -$8.66M -23,340 -0.9%
Northern Trust
17
Northern Trust
Illinois
$818M -$16M -43,039 -2%
Citigroup
18
Citigroup
New York
$811M +$689M +1,858,013 +778%
UBS AM
19
UBS AM
Illinois
$799M -$168M -453,078 -18%
Hotchkis & Wiley Capital Management
20
Hotchkis & Wiley Capital Management
California
$780M -$65M -175,363 -8%
Goldman Sachs
21
Goldman Sachs
New York
$776M +$196M +529,430 +36%
Nuveen
22
Nuveen
North Carolina
$770M +$10.8M +29,158 +1%
Massachusetts Financial Services
23
Massachusetts Financial Services
Massachusetts
$749M -$111M -300,249 -13%
Bank of America
24
Bank of America
North Carolina
$699M -$338M -912,499 -34%
Charles Schwab
25
Charles Schwab
California
$698M +$12.3M +33,208 +2%
1
2 3 4 5

ELV Hedge Fund Activity: Q2 2026 in Review

1,596 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q2 2026, worth a combined $76.6B — up 34% from $57B a quarter earlier.

Buyers outnumbered sellers: 262 funds opened new ELV positions and 104 closed out — a net gain of 158 holders — while 589 added to existing stakes and 540 trimmed.

The largest buyer was Citigroup, adding an estimated $689M. The largest seller was Amundi, cutting an estimated $389M.

  • 1,596 institutional investors held Elevance Health (ELV) as of Q2 2026, up from 1,468 in Q1 2026.
  • Funds reported $76.6B of Elevance Health stock for Q2 2026, up 34% quarter-over-quarter.
  • 262 funds opened new Elevance Health positions in Q2 2026 and 104 closed out, a net change of +158 holders.
  • The largest Elevance Health buyer in Q2 2026 was Citigroup, an estimated $689M added.
  • The largest Elevance Health seller in Q2 2026 was Amundi, an estimated $389M sold.

Based on aggregated 13F filings for Q2 2026.